Showing results (871-880 of 1,120) with videos related to
Sort By:
Pageof 112
The American Journal of Medicine|April 30, 2016
North American Thrombosis Forum, AF Action Initiative Consensus DocumentChristian T Ruff, Jack E Ansell, Richard C Becker, et al.JAMA Cardiology|March 26, 2025
Asundexian or Apixaban in Patients With Atrial Fibrillation According to Prior Oral Anticoagulant Use: A Subgroup Analysis of the OCEANIC-AF Randomized Clinical TrialJohn H Alexander, Elizabeth J Lydon, Jonathan P Piccini, et al.International Journal of Cardiology. Heart & Vasculature|August 4, 2021
High risk coronavirus disease 2019: The primary results of the CoronaHeart multi-center cohort studyPatrícia O Guimarães, Francis R de Souza, Renato D Lopes, et al.JAMA Neurology|May 7, 2019
Effect of a Quality Improvement Intervention on Adherence to Therapies for Patients With Acute Ischemic Stroke and Transient Ischemic Attack: A Cluster Randomized Clinical TrialM Julia Machline-Carrion, Eliana Vieira Santucci, Lucas Petri Damiani, et al.Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|November 17, 2017
Pathophysiology and Risk of Atrial Fibrillation Detected after Ischemic Stroke (PARADISE): A Translational, Integrated, and Transdisciplinary ApproachMaryse Paquet, Joshua O Cerasuolo, Victoria Thorburn, et al.American Heart Journal|November 29, 2016
Atorvastatin for high-risk statin-naïve patients undergoing noncardiac surgery: The Lowering the Risk of Operative Complications Using Atorvastatin Loading Dose (LOAD) randomized trialOtavio Berwanger, Pedro G M de Barros E Silva, Roberto Ramos Barbosa, et al.The New England Journal of Medicine|September 3, 2024
Asundexian versus Apixaban in Patients with Atrial FibrillationJonathan P Piccini, Manesh R Patel, Jan Steffel, et al.American Heart Journal|November 12, 2018
An international cluster-randomized quality improvement trial to increase the adherence to evidence-based therapies for acute ischemic stroke and transient ischemic attack patients: Rationale and design of the BRIDGE STROKE TrialMaria Julia Machline-Carrion, Eliana Vieira Santucci, Lucas Petri Damiani, et al.Chest|November 18, 2023
Symptoms and Impaired Quality of Life After COVID-19 Hospitalization: Effect of Therapeutic Heparin in Non-ICU Patients in the Accelerating COVID-19 Therapeutic Interventions and Vaccines 4 Acute Trial: Effect on 3-Month Symptoms and Quality of LifeYonatan Y Greenstein, Kinsley Hubel, Joshua Froess, et al.Stroke|May 25, 2016
First-Ever Stroke and Transient Ischemic Attack Incidence and 30-Day Case-Fatality Rates in a Population-Based Study in ArgentinaM Cecilia Bahit, Mariano L Coppola, Patricia M Riccio, et al.Pageof 112